Articles

How many times have you heard in your organisation:‘oh you can’t do that here, it’s impossible.’ Perhaps it’s something you’ve quietly thought yourself. While change is very often a great thing, bringing more good than bad to an organisation, many of us look at it as a time-consuming upheaval to our daily working lives and prefer to recoil into the comfortable space of the familiar. Pharma IQ has put the feelers out into the Biotech community and come up with some Top Tips which will help make what appears impossible in your organisation, possible Read more

Social media and the internet are increasingly been used as a means to sell illegal and counterfeit drugs, a UN drugs agency has warned. This comes in the wake of a recent industry alarm when fake batches of the cancer drug Avastin came onto the US market increasing fears about drug safety. A recent report by MarkMonitor estimated that online counterfeit sales cost businesses $135 billion (£87 billion) in revenue in 2011. Read more

Big Pharma is continually searching for new revenue generation models against increasing costs. External factors such as stringent health care reforms worldwide and the pressure to drive drug costs down from developing economies are only exacerbating challenges faced by the industry. The common thread to help alleviate these concerns is a concerted effort by these organizations to structure and tighten their supply chain and distribution capabilities. Read more

As the distribution of biologics becomes more complex, the associated challenges for compliance, quality and security are likely to increase. Demand for biologics in the United States is expected to exceed $100 billion in 2015. But in meeting this demand, companies are expected to take an increasingly global view. Read more

Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up. Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection (CBP) last year. Read more

"This year I am excited to be attending the conference as the topics are current and the case studies, solutions discussed, and tools to use will be of tremendous value to myself and all the attendees," said Steve Jacobs, Chair of the Global Clinical Supplies Group. Read more

The Middle East is one of the largest and most complex regions in the world, home to countries which are suffering from political tension or providing an abode for people in need of pharmaceuticals. Logistics throughout the area is the key factor in delivering products safely to those who are most in need. Read more

“Puff,” the mighty, magic outsourcing dragon is the “jack-of-all-trades” but master of none, trying to make sure that all roads lead to globalisation. Read more

The stakes are high: When an outsourcing relationship goes wrong, it can cost huge sums of money, erode market share, and ruin consumer confidence in a company or brand. Read more

“Think Global, Act Sectoral” is the new word to overcome an immense talent shortage. Governments all over the world are grappling with the question of how to increase competitiveness in a globalised world, and improve the quality of skills for innovation. Read more

In an ever more global industry, pharmaceutical distribution is among the most pressing issues facing every drug maker worldwide. Partnerships between pharma and logistics firms must be based on mutual understanding and trust if supply chains are going to work, with product integrity intact throughout the journey from lab to end user. Read more